Management of Thyroid Disease
The primary treatment for hypothyroidism is synthetic levothyroxine (LT4), while hyperthyroidism is primarily managed with antithyroid medications (methimazole or propylthiouracil), beta-blockers, radioactive iodine therapy, or surgery depending on the cause and severity. 1
Hypothyroidism Management
First-line Treatment
- Synthetic levothyroxine (LT4) is the standard treatment to normalize TSH levels 1, 2
- Initial dosing recommendations:
Monitoring and Dose Adjustment
- Check TSH and free T4 levels 6-8 weeks after starting treatment or changing dose 1, 2
- Once stable, monitor annually 1, 2
- Target TSH levels vary by patient population:
Special Considerations
- Important safety note: In patients with suspected central hypothyroidism, initiate cortisol replacement 1 week before starting levothyroxine to prevent adrenal crisis 1
- Combination therapy with T3 (liothyronine) is generally not recommended despite persistent symptoms in some patients with normal TSH 3
Hyperthyroidism Management
Medical Treatment
- Antithyroid medications:
- Beta-blockers (e.g., propranolol 60-80 mg orally every 4-6 hours) to control symptoms until antithyroid medications take effect 1
- Non-dihydropyridine calcium channel blockers (diltiazem, verapamil) when beta-blockers are contraindicated 1
Thyroid Storm Management
- Requires aggressive treatment with:
- Antithyroid drugs (PTU or methimazole)
- Saturated solution of potassium iodide or sodium iodide
- Dexamethasone
- Beta-blockers (propranolol or esmolol for hemodynamic instability)
- Supportive care (oxygen, antipyretics, monitoring) 1
Complications of Thyroid Dysfunction
Cardiovascular Complications
- Low TSH levels increase risk of:
Bone Health
- Untreated subclinical hyperthyroidism and overtreatment with levothyroxine can reduce bone mineral density 1
- Particularly concerning in elderly patients 1
Common Pitfalls to Avoid
- Overtreatment with levothyroxine: Can cause iatrogenic hyperthyroidism leading to atrial fibrillation and osteoporosis 1
- Inadequate monitoring: Failure to check TSH and free T4 levels at appropriate intervals 1
- Medication interactions: Some medications interfere with levothyroxine absorption or metabolism, requiring dose adjustments 4
- Pregnancy management: Failure to increase levothyroxine dosage during pregnancy can lead to adverse maternal and fetal outcomes 3
- Subclinical hypothyroidism overtreatment: Most patients with subclinical hypothyroidism do not benefit from treatment unless TSH >10 mIU/L or thyroid peroxidase antibody is elevated 3
By following these evidence-based guidelines for thyroid disease management, clinicians can effectively treat both hypothyroidism and hyperthyroidism while minimizing complications and optimizing patient outcomes.